Search Thermo Fisher Scientific
ECCMID 2022 Resource Center
We're here to empower your expertise with comprehensive solutions to support your lab in sepsis diagnosis and treatment, infectious disease testing and environmental sustainability.
 | On demand symposium talks:Moving insights into action: How innovative rapid diagnostic impact treatment decisions |
Timely detection of bacteria, viruses, and their associated drug resistance could guide treatment decisions, and in the age of rampant antimicrobiological resistance (AMR), it's more important than ever to fast forward results for the critically ill. Learn how innovative diagnostics could be the key to adjusting treatment staying ahead of AMR and advancing antimicrobial stewardship.
Explore the talks you may have missed or watch your favorites again on-demand.
Eight-year trend in HIV drug resistance at a national reference facility in metropolitan Lagos, Nigeria
Prof. Chika Onwuamah, Chief Research Scientist, Population Genomics and Cancer Group, Centre for Human Virology and Genomics, Nigeria
SARS-CoV-2 whole genome sequencing for variant surveillance
Dr. Rob Schuurman, Medical Molecular Microbiologist, UMC Utrecht, The Netherlands
Antibiotic treatment duration—when less is more
Prof. Evangelos Giamarellos-Bourboulis, Attikon University Hospital, Athens, Greece
Challenges and opportunities in early recognition of sepsis—how structured processes can help
Dr. Laura Evans, Medical Director, University of Washington, USA
Time is everything—opportunities for improving antimicrobial therapy in severe infections
Prof. Jan De Waele, Intensivist, Ghent University Hospital, Belgium
The symposium was chaired by:
Dr. Nicolla Pretosillo
MD FESCMID Head, Infection Prevention & Control-Infectious Disease Service Foundation, University Hospital Campus Bio-medico, Rome, Italy
Prof. John Rossen
Professor for Medical Microbiology, University of Groningen, University Medical Center Groningen, The Netherlands.
 |
|
Explore the latest product innovations and hot research topics in the field of clinical microbiology and infectious diseases. Watch the short 10-minute talks to be fully informed
PART I:
PART II:
Resources
Support
*Product is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status.
Q-linea AB is the legal manufacturer of ASTar®. ASTar® is a trademark of Q-linea AB. The ASTar system is distributed globally by Thermo Fisher Scientific.
Not all products are available for sale in all territories.